title: Interactions between the embryo and corpus luteum.
abstract: A total of 102 patients who had become pregnant following in-vitro fertilization (IVF) and embryo transfer were studied at weekly intervals between 4 and 14 weeks gestation. The pregnancies were classified as follows: (i) normal singleton, n = 52; (ii) normal twin, n = 24; (iii) heterotopic, n = 4 (weeks 4-8 only); and (iv) anembryonic with a viable intra-uterine singleton, n = 22. The serum concentrations of human chorionic gonadotrophin (hCG), Schwangerschaft protein-1 (SP-1) and pregnancy-associated plasma protein-A (PAPP-A), oestradiol and progesterone were measured. The mean serum concentrations of HCG, SP-1 and PAPP-A were significantly less in heterotopic than in singleton, singleton/anembryonic or twin pregnancies (P < 0.01-0.05), while those of progesterone and oestradiol were not different at any time. There were no significant differences between the serum concentrations of any of the substances analysed in singleton/anembryonic and singleton pregnancies, but the concentrations of all the substances analysed were significantly greater in twin pregnancies from as early as 7 weeks (P < 0.01-0.05). These data show that in heterotopic pregnancies trophoblast function is reduced, as suggested by the lower concentrations of the placental proteins. Despite this the concentrations of oestradiol and progesterone, derived predominantly from the corpus luteum between 4 and 8 weeks, are equivalent to those found in twin pregnancies, and greater than those found in singleton and singleton/anembryonic pregnancies. These findings support the notion that although HCG may rescue the corpus luteum it does not subsequently have a direct effect on its function, and suggest that the embryo may influence corpus luteum function.
authors.affiliation: Academic Department of Obstetrics and Gynaecology, Chelsea and Westminister Hospital, London, UK.
authors.forename: M R
authors.initials: MR
authors.lastname: Johnson
authors.forename: V N
authors.initials: VN
authors.lastname: Bolton
authors.forename: A F
authors.initials: AF
authors.lastname: Riddle
authors.forename: V
authors.initials: V
authors.lastname: Sharma
authors.forename: K
authors.initials: K
authors.lastname: Nicolaides
authors.forename: J G
authors.initials: JG
authors.lastname: Grudzinskas
authors.forename: W P
authors.initials: WP
authors.lastname: Collins
mesh_terms: D006063:Chorionic Gonadotropin / Q000097:blood; D003338:Corpus Luteum / Q000502:physiology*; D004624:Embryo Transfer; D004622:Embryo, Mammalian / Q000502:physiology*; D004958:Estradiol / Q000378:metabolism; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D010062:Ovulation Induction; D011247:Pregnancy; D011256:Pregnancy Outcome; D011257:Pregnancy Proteins / Q000097:blood; D011271:Pregnancy, Ectopic / Q000097:blood; D011266:Pregnancy-Associated Plasma Protein-A / Q000378:metabolism; D011374:Progesterone / Q000378:metabolism
chemical_list: D006063:Chorionic Gonadotropin; D011257:Pregnancy Proteins; D011374:Progesterone; D004958:Estradiol; D011266:Pregnancy-Associated Plasma Protein-A